Viewing Study NCT02890069

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:04 PM
Ignite Modification Date: 2026-02-24 @ 10:20 PM
Study NCT ID: NCT02890069
Status: COMPLETED
Last Update Posted: 2023-01-11
First Post: 2016-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast … View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PDR001 View
None CRC View
None TNBC View
None NSCLC View
None RCC View
None Immunomodulation View
None Biomarkers View
None Bayesian logistic regression model View